HuGE Literature Finder
Records
1
-
9
| The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors. Journal of cancer research and clinical oncology 2021 Sep . Kim Hana, Ahn Soomin, Kim Hongsik, Hong Jung Yong, Lee Jeeyun, Park Se Hoon, Park Joon Oh, Park Young Suk, Lim Ho Yeong, Kang Won Ki, Kim Kyoung-Mee, Kim Seung T |
| Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma. JCO precision oncology 2021 5 . Kim Jung, Light Nicholas, Subasri Vallijah, Young Erin L, Wegman-Ostrosky Talia, Barkauskas Donald A, Hall David, Lupo Philip J, Patidar Rajesh, Maese Luke D, Jones Kristine, Wang Mingyi, Tavtigian Sean V, Wu Dongjing, Shlien Adam, Telfer Frank, Goldenberg Anna, Skapek Stephen X, Wei Jun S, Wen Xinyu, Catchpoole Daniel, Hawkins Douglas S, Schiffman Joshua D, Khan Javed, Malkin David, Stewart Douglas |
| Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas. International journal of clinical oncology 2019 May . Liang Xiaohong, Li Qing, Xu Bin, Hu Song, Wang Qianyun, Li Yan, Zong Yun, Zhang Sujuan, Li Cho |
| Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers. Cancer 2019 Mar 125 (5): 698-703. Laitman Yael, Michaelson-Cohen Rachel, Levi Einat, Chen-Shtoyerman Rakefet, Reish Orit, Josefsberg Ben-Yehoshua Sagi, Bernstein-Molho Rinat, Keinan-Boker Lital, Rosengarten Ora, Silverman Barbara G, Perri Tamar, Korach Jacob, Mor Pnina, Ephrat Ben-Baruch Noa, Levy Lahad Ephrat, Friedman Eitan, |
| Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma. Cancer biology & therapy 2016 Oct 17 (10): 1017-1021. Miolo Gianmaria, Viel Alessandra, Canzonieri Vincenzo, Baresic Tania, Buonadonna Angela, Santeufemia Davide Adriano, Lara Della Puppa, Corona Giusep |
| The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS genetics 2014 Jul 10 (7): e1004475. Brohl Andrew S, Solomon David A, Chang Wendy, Wang Jianjun, Song Young, Sindiri Sivasish, Patidar Rajesh, Hurd Laura, Chen Li, Shern Jack F, Liao Hongling, Wen Xinyu, Gerard Julia, Kim Jung-Sik, Lopez Guerrero Jose Antonio, Machado Isidro, Wai Daniel H, Picci Piero, Triche Timothy, Horvai Andrew E, Miettinen Markku, Wei Jun S, Catchpool Daniel, Llombart-Bosch Antonio, Waldman Todd, Khan Jav |
| TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families. Hereditary cancer in clinical practice 2014 12 (1): 8. Cury Nathalia M, Ferraz Victor Ef, Silva Wilson |
| Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations. Breast cancer research and treatment 2013 Jul 140 (1): 207-11. Kadouri Luna, Sagi Michal, Goldberg Yael, Lerer Israela, Hamburger Tamar, Peretz Tam |
| Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast cancer research : BCR 2012 14 (2): R66. Lee Daphne S C, Yoon Sook-Yee, Looi Lai Meng, Kang Peter, Kang In Nee, Sivanandan Kavitta, Ariffin Hany, Thong Meow Keong, Chin Kin Fah, Mohd Taib Nur Aishah, Yip Cheng-Har, Teo Soo-Hwa |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: